5 Biggest Health Care Companies in Australia, 2024

2. Cochlear Limited

Market Cap: $15.9 billion

Cochlear Limited, a healthcare leader in implantable hearing solutions since 1981, invests heavily in R&D, exceeding $180 million annually. Their innovative products, including the Cochlear Osia 2 System and Cochlear Nucleus sound processors, have transformed the lives of over 600,000 individuals with hearing loss. Cochlear advocates for policies enhancing accessibility to hearing implants. In Q1 2024, the company reported a significant revenue increase of 24%, reaching AU$1.1 billion, with net income at AUD 191.4 million, and basic earnings per share of AUD 2.919.